BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30790292)

  • 1. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia.
    Wei M; Ma R; Huang S; Liao Y; Ding Y; Li Z; Guo Q; Tan R; Zhang L; Zhao L
    J Cell Physiol; 2019 Aug; 234(10):17392-17404. PubMed ID: 30790292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
    Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
    Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of HIF-1α inhibits the proliferation and migration of outer root sheath cells exposed to hypoxia in vitro: An involvement of Shh pathway.
    Zhang H; Nan W; Song X; Wang S; Si H; Li G
    Life Sci; 2017 Dec; 191():82-89. PubMed ID: 29030089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.
    Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C
    Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI1 is involved in HIF-1α-induced migration, invasion, and epithelial-mesenchymal transition in glioma cells.
    Lin Y; Guo L
    Folia Histochem Cytobiol; 2022; 60(2):156-166. PubMed ID: 35603730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
    Chen JC; Hwang JH
    In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy.
    Newcomb EW; Ali MA; Schnee T; Lan L; Lukyanov Y; Fowkes M; Miller DC; Zagzag D
    Neuro Oncol; 2005 Jul; 7(3):225-35. PubMed ID: 16053697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
    Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
    Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
    Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
    Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
    Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
    Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
    Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
    Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
    [No Abstract]   [Full Text] [Related]  

  • 14. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription.
    Liu Y; Wang X; Li W; Xu Y; Zhuo Y; Li M; He Y; Wang X; Guo Q; Zhao L; Qiang L
    Oncogene; 2020 Nov; 39(45):6893-6905. PubMed ID: 32978517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling.
    Chen S; Zhang M; Xing L; Wang Y; Xiao Y; Wu Y
    PLoS One; 2015; 10(3):e0121115. PubMed ID: 25811359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.
    Lo Dico A; Martelli C; Valtorta S; Raccagni I; Diceglie C; Belloli S; Gianelli U; Vaira V; Politi LS; Bosari S; Lucignani G; Moresco RM; Ottobrini L
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1093-105. PubMed ID: 25813354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
    Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
    J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
    Tabatabai G; Frank B; Möhle R; Weller M; Wick W
    Brain; 2006 Sep; 129(Pt 9):2426-35. PubMed ID: 16835250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway.
    Qin Y; Liu HJ; Li M; Zhai DH; Tang YH; Yang L; Qiao KL; Yang JH; Zhong WL; Zhang Q; Liu YR; Yang G; Sun T; Yang C
    EBioMedicine; 2018 Dec; 38():25-36. PubMed ID: 30396856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.